1
Return

Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV

delete2026-07-06
delete0
delete
OA
AI
A
Ashma Chakrawarti
R
Ross T Cromarty
C
Christopher M Basting
J
Jodi Anderson
T
Ty A Schroeder
K
Kevin Escandón
R
Robin Shields-Cutler
R
Robert Langat
E
Erik Swanson
P
Patrick Soon-Shiong
J
Jeffrey T Safrit
L
Leonard S Sender
S
Sandeep Reddy
J
Jeffrey S Miller
J
Joshua Rhein
T
Timothy W Schacker *
N
Nichole R Klatt *
DOI：10.1093/cid/ciag369delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
N-803, an IL-15 superagonist, is currently being studied in clinical trials as a treatment to reverse HIV latency. However, its effects on the gut microbiome are not well understood.

Journal

Clinical Infectious Diseases cover
Clinical Infectious Diseases
IF:
7.3
Papers:
2.6W
Citations:
7.8W

Organization

I
immunitybio
Scholars:
10
Papers: 5
Citations: 0
U
university of minnesota
Scholars:
3.2K
Papers: 1.5K
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers